Aimmune Therapeutics (AIMT) PT Raised to $44 at JMP Securities
Tweet
Share
E-mailGet Alerts AIMT Hot Sheet
Price: $34.49 --0%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 34
Join SI Premium – FREE
JMP Securities analyst Liisa Bayko raised the price target on Aimmune Therapeutics (NASDAQ: AIMT) to $44.00 (from $40.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- The Lovesac Co. (LOVE) PT Lowered to $18 at DA Davidson as Guidance Lowered
- Bank Rakyat Indonesia Persero Tbk PT (BBRI:IJ) (BKRKF) PT Raised to IDR2,860 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
